{"component": "clause", "props": {"groups": [{"size": 30, "samples": [{"hash": "1hIdkR6hLya", "uri": "/contracts/1hIdkR6hLya#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 27.9556510211, "published": true}, {"hash": "h4BNQbZrsL4", "uri": "/contracts/h4BNQbZrsL4#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 27.7722473933, "published": true}], "snippet": "Quintiles and/or Sponsor may terminate this Agreement for any reason effective immediately upon written notice. Quintiles a/nebo Zadavatel jsou opr\u00e1vn\u011bni ukon\u010dit platnost t\u00e9to Smlouvy z jak\u00e9hokoli d\u016fvodu s okam\u017eitou \u00fa\u010dinnost\u00ed neprodlen\u011b na z\u00e1klad\u011b doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed. The Site may terminate upon written notice if circumstances beyond the Site\u2019s reasonable control prevent completion of the Study, or if it reasonably determines that it is unsafe to continue the Study. Upon receipt of notice of termination, the Site shall immediately cease any subject recruitment, follow the specified termination procedures, ensure that any required subject follow-up procedures are completed, and make all reasonable efforts to minimize further costs, and Quintiles shall make a final payment for visits or milestones properly performed pursuant to this Agreement in the amounts specified in Attachment A; provided, however, that Payments will be in each case reduced by ten (10 %) percent. This reduced amount shall represent a value of any/all activities related to close-out of the database, and will be made upon the final acceptance by Sponsor of all CRF pages and all data clarifications issued and satisfaction of all other applicable conditions set forth herein. If a material breach of this Agreement appears to have occurred and termination may be required, then, except to the extent that Study Subject safety may be jeopardized, Quintiles and/or Sponsor may suspend performance of all or part of this Agreement, including, but not limited to, subject enrollment. M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed je opr\u00e1vn\u011bno ukon\u010dit platnost t\u00e9to Smlouvy p\u00edsemn\u00fdm ozn\u00e1men\u00edm v p\u0159\u00edpad\u011b, \u017ee okolnosti, je\u017e jsou svoj\u00ed povahou mimo mo\u017enost ovlivn\u011bn\u00ed ze strany M\u00edsta prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed, zabr\u00e1n\u00ed dokon\u010den\u00ed Studie, nebo v p\u0159\u00edpad\u011b, \u017ee M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed d\u016fvodn\u011b usoud\u00ed, \u017ee pokra\u010dov\u00e1n\u00ed ve Studii nen\u00ed bezpe\u010dn\u00e9. V n\u00e1vaznosti na doru\u010den\u00ed ozn\u00e1men\u00ed o ukon\u010den\u00ed platnosti M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed neprodlen\u011b ukon\u010d\u00ed jak\u00fdkoli n\u00e1bor subjekt\u016f, bude jednat v souladu s definovan\u00fdmi postupy pro ukon\u010den\u00ed, zajist\u00ed, \u017ee ve vztahu k subjekt\u016fm Studie budou dokon\u010deny jak\u00e9koli procesy kontroln\u00ed povahy, a vyvinou nezbytn\u00e9 \u00fasil\u00ed za \u00fa\u010delem limitace jak\u00fdchkoli dal\u0161\u00edch n\u00e1klad\u016f, p\u0159i\u010dem\u017e Quintiles provede z\u00e1v\u011bre\u010dnou \u00fahradu za n\u00e1v\u0161t\u011bvy a miln\u00edky, je\u017e byly \u0159\u00e1dn\u011b provedeny na z\u00e1klad\u011b a v souladu s touto Smlouvou, a to ve v\u00fd\u0161i \u010d\u00e1stek definovan\u00fdch v P\u0159\u00edloze A; av\u0161ak za podm\u00ednky, \u017ee Platby budou v ka\u017ed\u00e9m p\u0159\u00edpad\u011b sn\u00ed\u017eeny o \u010d\u00e1stku ve v\u00fd\u0161i deseti (10 %) procent. Takto sn\u00ed\u017een\u00e1 \u010d\u00e1stka bude p\u0159edstavovat hodnotu ve\u0161ker\u00fdch \u010dinnost\u00ed spojen\u00fdch s uzav\u0159en\u00edm datab\u00e1ze, a bude poskytnuta pot\u00e9, co Zadavatel schv\u00e1l\u00ed ve\u0161ker\u00e9 str\u00e1nky formul\u00e1\u0159\u016f CRF, a d\u00e1le pot\u00e9, co budou poskytnuta ve\u0161ker\u00e1 vyjasn\u011bn\u00ed dat a d\u00e1le dojde ke spln\u011bn\u00ed ve\u0161ker\u00fdch ostatn\u00edch podm\u00ednek, je\u017e jsou stanoveny v t\u00e9to Smlouv\u011b. V p\u0159\u00edpad\u011b, \u017ee dojde ke vzniku domn\u011bn\u00ed, \u017ee do\u0161lo k podstatn\u00e9mu poru\u0161en\u00ed t\u00e9to Smlouvy a m\u016f\u017ee tak doj\u00edt k ukon\u010den\u00ed platnosti t\u00e9to Smlouvy, pak s v\u00fdjimkou a \u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587 ohro\u017eena bezpe\u010dnost Subjekt\u016f studie, Quintiles a/nebo Zadavatel mohou p\u0159eru\u0161it napln\u011bn\u00ed cel\u00e9 \u010di \u010d\u00e1sti t\u00e9to Smlouvy, zejm\u00e9na v\u010detn\u011b za\u0159azov\u00e1n\u00ed Subjekt\u016f studie.", "snippet_links": [{"key": "for-any-reason", "type": "clause", "offset": [54, 68]}, {"key": "upon-written-notice", "type": "clause", "offset": [91, 110]}, {"key": "the-site", "type": "clause", "offset": [277, 285]}, {"key": "reasonable-control", "type": "clause", "offset": [355, 373]}, {"key": "completion-of-the-study", "type": "clause", "offset": [382, 405]}, {"key": "notice-of-termination", "type": "clause", "offset": [495, 516]}, {"key": "subject-recruitment", "type": "clause", "offset": [555, 574]}, {"key": "termination-procedures", "type": "clause", "offset": [597, 619]}, {"key": "efforts-to-minimize", "type": "clause", "offset": [714, 733]}, {"key": "further-costs", "type": "clause", "offset": [734, 747]}, {"key": "payment-for", "type": "clause", "offset": [782, 793]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [834, 860]}, {"key": "attachment-a", "type": "definition", "offset": [889, 901]}, {"key": "each-case", "type": "definition", "offset": [947, 956]}, {"key": "reduced-amount", "type": "definition", "offset": [993, 1007]}, {"key": "related-to", "type": "clause", "offset": [1054, 1064]}, {"key": "the-database", "type": "definition", "offset": [1078, 1090]}, {"key": "by-sponsor", "type": "clause", "offset": [1135, 1145]}, {"key": "satisfaction-of", "type": "clause", "offset": [1202, 1217]}, {"key": "other-applicable-conditions", "type": "clause", "offset": [1222, 1249]}, {"key": "material-breach-of-this-agreement", "type": "clause", "offset": [1273, 1306]}, {"key": "and-termination", "type": "clause", "offset": [1332, 1347]}, {"key": "except-to-the-extent", "type": "clause", "offset": [1371, 1391]}, {"key": "subject-safety", "type": "clause", "offset": [1403, 1417]}, {"key": "suspend-performance", "type": "clause", "offset": [1467, 1486]}, {"key": "not-limited", "type": "clause", "offset": [1536, 1547]}, {"key": "subject-enrollment", "type": "clause", "offset": [1552, 1570]}, {"key": "prov\u00e1d\u011bn\u00ed-klinick\u00e9ho-hodnocen\u00ed", "type": "clause", "offset": [1578, 1608]}, {"key": "dokon\u010den\u00ed-studie", "type": "clause", "offset": [1798, 1814]}, {"key": "n\u00e1bor-subjekt\u016f", "type": "clause", "offset": [2047, 2061]}, {"key": "a-\u2587", "type": "clause", "offset": [3034, 3037]}], "hash": "bc8d3d45de6ef83c158479809d556552", "id": 1}, {"size": 19, "samples": [{"hash": "bm4D0QJ0n1s", "uri": "/contracts/bm4D0QJ0n1s#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 29.6094754957, "published": true}], "snippet": "IQVIA and/or Sponsor may terminate this Agreement for any reason effective immediately upon written notice received by the Institution. The Site may terminate immediately upon \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 receipt of written notice if circumstances beyond the Site\u2019s reasonable control prevent completion of the Study, or if it reasonably proves that it is unsafe to continue the Study. The Institution may also terminate this Agreement in writing if, as a result of a hindrance beyond the Institution\u2019s control, the Institution is rendered, for a long-term incapable, to complete the Study, without its main operation being hindered, which is the provision of healthcare services. The notice period shall be thirty (30) days and shall start on the day following the day of its receipt by Sponsor, IQVIA and the Investigator. Upon receipt of notice of termination, the Site shall immediately cease any subject recruitment, follow the IQVIA a/nebo Zadavatel jsou opr\u00e1vn\u011bni ukon\u010dit platnost t\u00e9to Smlouvy z jak\u00e9hokoli d\u016fvodu s okam\u017eitou \u00fa\u010dinnost\u00ed ke dni doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed Zdravotnick\u00e9mu za\u0159\u00edzen\u00ed. M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed je opr\u00e1vn\u011bno okam\u017eit\u011b ukon\u010dit platnost t\u00e9to Smlouvy ke dni doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed Zadavateli v p\u0159\u00edpad\u011b, \u017ee okolnosti, je\u017e jsou svoj\u00ed povahou mimo mo\u017enost ovlivn\u011bn\u00ed ze strany M\u00edsta prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed, zabr\u00e1n\u00ed dokon\u010den\u00ed Studie, nebo v p\u0159\u00edpad\u011b, \u017ee M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed d\u016fvodn\u011b dolo\u017e\u00ed, \u017ee pokra\u010dov\u00e1n\u00ed ve Studii nen\u00ed bezpe\u010dn\u00e9. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je tak\u00e9 opr\u00e1vn\u011bno ukon\u010dit tuto Smlouvu p\u00edsemnou v\u00fdpov\u011bd\u00ed, nebude-li t\u00edm ohro\u017eena bezpe\u010dnost Subjekt\u016f studie, jestli\u017ee v d\u016fsledku vzniku p\u0159ek\u00e1\u017eky, je\u017e nastala nez\u00e1visle na jeho v\u016fli, nebude Zdravotnick\u00e9 za\u0159\u00edzen\u00ed dlouhodob\u011b schopno dokon\u010dit Studii, ani\u017e by t\u00edm nebyla negativn\u011b ovlivn\u011bna jeho hlavn\u00ed \u010dinnost, kterou je poskytov\u00e1n\u00ed zdravotn\u00ed p\u00e9\u010de. specified termination procedures, ensure that any required subject follow-up procedures are completed, and make all reasonable efforts to minimize further costs, and IQVIA shall make a final payment for visits or milestones properly performed pursuant to this Agreement in the amounts specified in Attachment A; provided, however, that Payments will be in each case reduced by ten (10 %) percent. This reduced amount shall represent a value of any/all activities related to close-out of the database, and will be made upon the final acceptance by Sponsor of all CRF pages and all data clarifications issued and satisfaction of all other applicable conditions set forth herein. If a material breach of this Agreement appears to have occurred and termination may be required, then, except to the extent that Study Subject safety may be jeopardized, IQVIA and/or Sponsor may suspend performance of all or part of this Agreement, including, but not limited to, subject enrollment. V\u00fdpov\u011bdn\u00ed doba \u010din\u00ed t\u0159icet (30) dn\u016f a po\u010d\u00edn\u00e1 b\u011b\u017eet dnem n\u00e1sleduj\u00edc\u00edm po dni doru\u010den\u00ed t\u00e9to v\u00fdpov\u011bdi Zadavateli, IQVIA a Zkou\u0161ej\u00edc\u00edmu. V n\u00e1vaznosti na doru\u010den\u00ed ozn\u00e1men\u00ed o ukon\u010den\u00ed platnosti M\u00edsto prov\u00e1d\u011bn\u00ed klinick\u00e9ho hodnocen\u00ed neprodlen\u011b ukon\u010d\u00ed jak\u00fdkoli n\u00e1bor subjekt\u016f, bude jednat v souladu s definovan\u00fdmi postupy pro ukon\u010den\u00ed, zajist\u00ed, \u017ee ve vztahu k subjekt\u016fm Studie budou dokon\u010deny jak\u00e9koli procesy kontroln\u00ed povahy, a vyvinou nezbytn\u00e9 \u00fasil\u00ed za \u00fa\u010delem limitace jak\u00fdchkoli dal\u0161\u00edch n\u00e1klad\u016f, p\u0159i\u010dem\u017e IQVIA provede z\u00e1v\u011bre\u010dnou \u00fahradu za n\u00e1v\u0161t\u011bvy a miln\u00edky, je\u017e byly \u0159\u00e1dn\u011b provedeny na z\u00e1klad\u011b a v souladu s touto Smlouvou, a to ve v\u00fd\u0161i \u010d\u00e1stek definovan\u00fdch v P\u0159\u00edloze A; av\u0161ak za podm\u00ednky, \u017ee Platby budou v ka\u017ed\u00e9m p\u0159\u00edpad\u011b sn\u00ed\u017eeny o \u010d\u00e1stku ve v\u00fd\u0161i deseti (10 %) procent. Takto sn\u00ed\u017een\u00e1 \u010d\u00e1stka bude p\u0159edstavovat hodnotu ve\u0161ker\u00fdch \u010dinnost\u00ed spojen\u00fdch s uzav\u0159en\u00edm datab\u00e1ze, a bude poskytnuta pot\u00e9, co Zadavatel schv\u00e1l\u00ed ve\u0161ker\u00e9 str\u00e1nky formul\u00e1\u0159\u016f CRF, a d\u00e1le pot\u00e9, co budou poskytnuta ve\u0161ker\u00e1 vyjasn\u011bn\u00ed dat a d\u00e1le dojde ke spln\u011bn\u00ed ve\u0161ker\u00fdch ostatn\u00edch podm\u00ednek, je\u017e jsou stanoveny v t\u00e9to Smlouv\u011b. V p\u0159\u00edpad\u011b, \u017ee dojde ke vzniku domn\u011bn\u00ed, \u017ee do\u0161lo k podstatn\u00e9mu poru\u0161en\u00ed t\u00e9to Smlouvy, m\u016f\u017ee doj\u00edt k ukon\u010den\u00ed platnosti t\u00e9to Smlouvy, a to s v\u00fdjimkou a v rozsahu, v jak\u00e9m m\u016f\u017ee b\u00fdt ohro\u017eena bezpe\u010dnost Subjekt\u016f studie. V takov\u00e9m p\u0159\u00edpad\u011b IQVIA a/nebo Zadavatel m\u016f\u017ee p\u0159eru\u0161it napln\u011bn\u00ed cel\u00e9 \u010di \u010d\u00e1sti t\u00e9to Smlouvy, zejm\u00e9na za\u0159azov\u00e1n\u00ed Subjekt\u016f studie. Notices shall be deemed to have been duly given under the following terms: Ozn\u00e1men\u00ed se pova\u017euji za \u0159\u00e1dn\u011b doru\u010den\u00e1 p\u0159i spln\u011bn\u00ed n\u011bkter\u00e9 z n\u00e1sleduj\u00edc\u00edch podm\u00ednek:\ni. upon personal delivery; ii. upon deposit in the mail if mailed by certified mail, return receipt requested, postage prepaid; i. osobn\u00edm doru\u010den\u00edm; ii. doru\u010den\u00edm do po\u0161ty, za p\u0159edpokladu, \u017ee bylo zasl\u00e1no jako doporu\u010den\u00e9/do vlastn\u00edch rukou, je vy\u017eadov\u00e1n doklad o doru\u010den\u00ed, po\u0161tovn\u00e9 je p\u0159edplaceno;", "snippet_links": [{"key": "for-any-reason", "type": "clause", "offset": [50, 64]}, {"key": "received-by", "type": "definition", "offset": [107, 118]}, {"key": "the-institution", "type": "clause", "offset": [119, 134]}, {"key": "the-site", "type": "clause", "offset": [136, 144]}, {"key": "receipt-of-written-notice", "type": "definition", "offset": [186, 211]}, {"key": "reasonable-control", "type": "clause", "offset": [247, 265]}, {"key": "completion-of-the-study", "type": "clause", "offset": [274, 297]}, {"key": "agreement-in-writing", "type": "clause", "offset": [407, 427]}, {"key": "a-long", "type": "clause", "offset": [526, 532]}, {"key": "complete-the", "type": "clause", "offset": [552, 564]}, {"key": "provision-of", "type": "clause", "offset": [628, 640]}, {"key": "healthcare-services", "type": "definition", "offset": [641, 660]}, {"key": "the-notice-period", "type": "clause", "offset": [662, 679]}, {"key": "the-day", "type": "definition", "offset": [725, 732]}, {"key": "following-the", "type": "definition", "offset": [733, 746]}, {"key": "day-of", "type": "clause", "offset": [747, 753]}, {"key": "by-sponsor", "type": "clause", "offset": [766, 776]}, {"key": "the-investigator", "type": "clause", "offset": [788, 804]}, {"key": "notice-of-termination", "type": "clause", "offset": [822, 843]}, {"key": "subject-recruitment", "type": "clause", "offset": [882, 901]}, {"key": "prov\u00e1d\u011bn\u00ed-klinick\u00e9ho-hodnocen\u00ed", "type": "clause", "offset": [1090, 1120]}, {"key": "dokon\u010den\u00ed-studie", "type": "clause", "offset": [1346, 1362]}, {"key": "zdravotnick\u00e9-za\u0159\u00edzen\u00ed", "type": "clause", "offset": [1476, 1497]}, {"key": "termination-procedures", "type": "clause", "offset": [1853, 1875]}, {"key": "efforts-to-minimize", "type": "clause", "offset": [1970, 1989]}, {"key": "further-costs", "type": "clause", "offset": [1990, 2003]}, {"key": "payment-for", "type": "clause", "offset": [2034, 2045]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [2086, 2112]}, {"key": "attachment-a", "type": "definition", "offset": [2141, 2153]}, {"key": "each-case", "type": "definition", "offset": [2199, 2208]}, {"key": "reduced-amount", "type": "definition", "offset": [2245, 2259]}, {"key": "related-to", "type": "clause", "offset": [2306, 2316]}, {"key": "the-database", "type": "definition", "offset": [2330, 2342]}, {"key": "acceptance-by", "type": "clause", "offset": [2376, 2389]}, {"key": "satisfaction-of", "type": "clause", "offset": [2454, 2469]}, {"key": "other-applicable-conditions", "type": "clause", "offset": [2474, 2501]}, {"key": "material-breach-of-this-agreement", "type": "clause", "offset": [2525, 2558]}, {"key": "and-termination", "type": "clause", "offset": [2584, 2599]}, {"key": "except-to-the-extent", "type": "clause", "offset": [2623, 2643]}, {"key": "subject-safety", "type": "clause", "offset": [2655, 2669]}, {"key": "suspend-performance", "type": "clause", "offset": [2715, 2734]}, {"key": "not-limited", "type": "clause", "offset": [2784, 2795]}, {"key": "subject-enrollment", "type": "clause", "offset": [2800, 2818]}, {"key": "n\u00e1bor-subjekt\u016f", "type": "clause", "offset": [3072, 3086]}, {"key": "personal-delivery", "type": "definition", "offset": [4414, 4431]}, {"key": "certified-mail", "type": "definition", "offset": [4475, 4489]}, {"key": "return-receipt-requested", "type": "clause", "offset": [4491, 4515]}], "hash": "528de6fcb3906ec64301a2a34c6ff489", "id": 2}, {"size": 14, "samples": [{"hash": "fUuZfafv1n4", "uri": "/contracts/fUuZfafv1n4#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 28.9073941058, "published": true}], "snippet": "IQVIA a/nebo Zadavatel jsou opr\u00e1vn\u011bni vypov\u011bd\u011bt tuto Smlouvu p\u00edsemn\u011b s v\u00fdpov\u011bdn\u00ed lh\u016ftou t\u0159iceti (30) dn\u016f. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je opr\u00e1vn\u011bno ukon\u010dit tuto Smlouvu z d\u016fvodu podstatn\u00e9ho poru\u0161en\u00ed ze strany Zadavatele \u010di IQVIA s t\u00edm, \u017ee za\u0161le IQVIA p\u00edsemnou v\u00fdzvu o poru\u0161en\u00ed a toto poru\u0161en\u00ed nen\u00ed napraveno do t\u0159iceti (30) dn\u00ed od doru\u010den\u00ed v\u00fdzvy IQVIA. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je opr\u00e1vn\u011bno ukon\u010dit platnost t\u00e9to Smlouvy p\u00edsemn\u00fdm ozn\u00e1men\u00edm v p\u0159\u00edpad\u011b, \u017ee okolnosti, je\u017e jsou svoj\u00ed povahou mimo mo\u017enost ovlivn\u011bn\u00ed ze strany Zdravotnick\u00e9ho za\u0159\u00edzen\u00ed, zabr\u00e1n\u00ed dokon\u010den\u00ed Studie, nebo v p\u0159\u00edpad\u011b, \u017eeZdravotnick\u00e9 za\u0159\u00edzen\u00edd\u016fvodn\u011b usoud\u00ed, \u017ee pokra\u010dov\u00e1n\u00ed ve Studii nen\u00ed bezpe\u010dn\u00e9. V n\u00e1vaznosti na doru\u010den\u00ed ozn\u00e1men\u00ed o ukon\u010den\u00ed platnosti Zdravotnick\u00e9 za\u0159\u00edzen\u00ed neprodlen\u011b ukon\u010d\u00ed jak\u00fdkoli n\u00e1bor subjekt\u016f, bude jednat v souladu s definovan\u00fdmi postupy pro ukon\u010den\u00ed, zajist\u00ed, \u017ee ve vztahu k subjekt\u016fm Studie budou dokon\u010deny jak\u00e9koli procesy kontroln\u00ed povahy, a vyvinou nezbytn\u00e9 \u00fasil\u00ed za \u00fa\u010delem limitace jak\u00fdchkoli dal\u0161\u00edch n\u00e1klad\u016f, p\u0159i\u010dem\u017e \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587 n\u00e1v\u0161t\u011bvy a miln\u00edky, je\u017e byly \u0159\u00e1dn\u011b provedeny na z\u00e1klad\u011b a v souladu s touto Smlouvou, a to ve v\u00fd\u0161i \u010d\u00e1stek definovan\u00fdchv P\u0159\u00edloze A; av\u0161ak za podm\u00ednky, \u017ee Platby budou v ka\u017ed\u00e9m p\u0159\u00edpad\u011b sn\u00ed\u017eeny o \u010d\u00e1stku ve v\u00fd\u0161i t\u0159iceti (30 %) procent. Takto sn\u00ed\u017een\u00e1 \u010d\u00e1stka bude p\u0159edstavovat hodnotu ve\u0161ker\u00fdch \u010dinnost\u00ed spojen\u00fdch s uzav\u0159en\u00edm datab\u00e1ze,a bude poskytnuta pot\u00e9, co Zadavatel schv\u00e1l\u00ed ve\u0161ker\u00e9 str\u00e1nky formul\u00e1\u0159\u016f CRF, a d\u00e1le pot\u00e9, co budou poskytnuta ve\u0161ker\u00e1 vyjasn\u011bn\u00ed dat a d\u00e1le dojde ke spln\u011bn\u00ed ve\u0161ker\u00fdch ostatn\u00edch podm\u00ednek, je\u017e jsou stanoveny v t\u00e9to Smlouv\u011b. V p\u0159\u00edpad\u011b, \u017ee dojde ke vzniku domn\u011bn\u00ed, \u017ee do\u0161lo k podstatn\u00e9mu poru\u0161en\u00ed t\u00e9to Smlouvy a m\u016f\u017ee tak doj\u00edt k ukon\u010den\u00ed platnosti t\u00e9to Smlouvy, pak s v\u00fdjimkou a \u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587 ohro\u017eena bezpe\u010dnost Subjekt\u016f studie,spole\u010dnosti IQVIA a/nebo Zadavatel mohou p\u0159eru\u0161it napln\u011bn\u00ed cel\u00e9 \u010di \u010d\u00e1sti t\u00e9to Smlouvy, zejm\u00e9na v\u010detn\u011b za\u0159azov\u00e1n\u00ed Subjekt\u016f studie.", "snippet_links": [{"key": "zdravotnick\u00e9-za\u0159\u00edzen\u00ed", "type": "clause", "offset": [106, 127]}, {"key": "ze-strany-zadavatele", "type": "clause", "offset": [192, 212]}, {"key": "dokon\u010den\u00ed-studie", "type": "clause", "offset": [544, 560]}, {"key": "n\u00e1bor-subjekt\u016f", "type": "clause", "offset": [761, 775]}, {"key": "a-\u2587", "type": "clause", "offset": [1743, 1746]}], "hash": "40705bc91b509b10df852044f38c0ff9", "id": 3}, {"size": 4, "samples": [{"hash": "6o2GIrXFaWg", "uri": "/contracts/6o2GIrXFaWg#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 29.3795501488, "published": true}], "snippet": "IQVIA a/nebo Zadavatel jsou opr\u00e1vn\u011bni ukon\u010dit platnost t\u00e9to Smlouvy z jak\u00e9hokoli d\u016fvodu s okam\u017eitou \u00fa\u010dinnost\u00ed neprodlen\u011b na z\u00e1klad\u011b doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je opr\u00e1vn\u011bno ukon\u010dit tuto Smlouvu z d\u016fvodu podstatn\u00e9ho poru\u0161en\u00ed s t\u00edm, \u017ee za\u0161le IQVIA p\u00edsemnou v\u00fdzvu o poru\u0161en\u00ed a toto poru\u0161en\u00ed nen\u00ed napraveno do t\u0159iceti (30) dn\u00ed od doru\u010den\u00ed v\u00fdzvy IQVIA. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je opr\u00e1vn\u011bno ukon\u010dit platnost t\u00e9to Smlouvy p\u00edsemn\u00fdm ozn\u00e1men\u00edm v p\u0159\u00edpad\u011b, \u017ee okolnosti, je\u017e jsou svoj\u00ed povahou mimo mo\u017enost ovlivn\u011bn\u00ed ze strany Zdravotnick\u00e9ho za\u0159\u00edzen\u00ed, zabr\u00e1n\u00ed dokon\u010den\u00ed Studie, nebo v p\u0159\u00edpad\u011b, \u017ee Zdravotnick\u00e9 za\u0159\u00edzen\u00ed d\u016fvodn\u011b usoud\u00ed, \u017ee pokra\u010dov\u00e1n\u00ed ve Studii nen\u00ed z medic\u00ednsk\u00e9ho hlediska od\u016fvodniteln\u00e9 z d\u016fvodu neo\u010dek\u00e1van\u00fdch v\u00fdsledk\u016f, z\u00e1va\u017enosti nebo prevalence z\u00e1va\u017en\u00fdch nep\u0159\u00edzniv\u00fdch p\u0159\u00edhod nebo nedostate\u010dn\u00e9ho \u00fa\u010dinku Hodnocen\u00e9ho l\u00e9\u010diva. V n\u00e1vaznosti na doru\u010den\u00ed ozn\u00e1men\u00ed o ukon\u010den\u00ed platnosti Zdravotnick\u00e9 za\u0159\u00edzen\u00ed neprodlen\u011b ukon\u010d\u00ed jak\u00fdkoli n\u00e1bor subjekt\u016f, bude jednat v souladu s definovan\u00fdmi postupy pro ukon\u010den\u00ed, zajist\u00ed, \u017ee ve vztahu k subjekt\u016fm Studie budou dokon\u010deny jak\u00e9koli procesy kontroln\u00ed povahy, a vyvinou nezbytn\u00e9 \u00fasil\u00ed za \u00fa\u010delem limitace jak\u00fdchkoli dal\u0161\u00edch n\u00e1klad\u016f, p\u0159i\u010dem\u017e IQVIA provede z\u00e1v\u011bre\u010dnou \u00fahradu za n\u00e1v\u0161t\u011bvy a miln\u00edky, je\u017e byly \u0159\u00e1dn\u011b provedeny na z\u00e1klad\u011b a v souladu s touto Smlouvou, a to and will be made upon the final acceptance by Sponsor of all CRF pages and all data clarifications issued and satisfaction of all other applicable conditions set forth herein. If a material breach of this Agreement appears to have occurred and termination may be required, then, except to the extent that Study Subject safety may be jeopardized, IQVIA and/or Sponsor may suspend performance of all or part of this Agreement, including, but not limited to, subject enrollment.", "snippet_links": [{"key": "zdravotnick\u00e9-za\u0159\u00edzen\u00ed", "type": "clause", "offset": [161, 182]}, {"key": "dokon\u010den\u00ed-studie", "type": "clause", "offset": [569, 585]}, {"key": "n\u00e1bor-subjekt\u016f", "type": "clause", "offset": [953, 967]}, {"key": "by-sponsor", "type": "clause", "offset": [1369, 1379]}, {"key": "satisfaction-of", "type": "clause", "offset": [1436, 1451]}, {"key": "other-applicable-conditions", "type": "clause", "offset": [1456, 1483]}, {"key": "material-breach-of-this-agreement", "type": "clause", "offset": [1507, 1540]}, {"key": "and-termination", "type": "clause", "offset": [1566, 1581]}, {"key": "except-to-the-extent", "type": "clause", "offset": [1605, 1625]}, {"key": "subject-safety", "type": "clause", "offset": [1637, 1651]}, {"key": "suspend-performance", "type": "clause", "offset": [1697, 1716]}, {"key": "not-limited", "type": "clause", "offset": [1766, 1777]}, {"key": "subject-enrollment", "type": "clause", "offset": [1782, 1800]}], "hash": "5f6d0d8924db82a106d3a89d13fe8c34", "id": 4}, {"size": 3, "samples": [{"hash": "NyVkZfcZEc", "uri": "/contracts/NyVkZfcZEc#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 28.7541015213, "published": true}, {"hash": "jpJxzCnx742", "uri": "/contracts/jpJxzCnx742#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 28.0889912643, "published": true}], "snippet": "15.2.1 Zadavatel je opr\u00e1vn\u011bn ukon\u010dit platnost t\u00e9to Smlouvy z jak\u00e9hokoli d\u016fvodu s okam\u017eitou \u00fa\u010dinnost\u00ed neprodlen\u011b na z\u00e1klad\u011b doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed.", "snippet_links": [], "hash": "e5929a24b3e12b59eef85c1eb465340c", "id": 5}, {"size": 3, "samples": [{"hash": "iFW1nRWBeRr", "uri": "/contracts/iFW1nRWBeRr#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 28.2360891353, "published": true}, {"hash": "aZW8T0A2DLf", "uri": "/contracts/aZW8T0A2DLf#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 26.7056810404, "published": true}], "snippet": "Sponsor may terminate this Agreement for any reason effective immediately upon written notice.", "snippet_links": [{"key": "for-any-reason", "type": "clause", "offset": [37, 51]}, {"key": "upon-written-notice", "type": "clause", "offset": [74, 93]}], "hash": "443e9561da4cee54c85fd54c8ff6d228", "id": 6}, {"size": 3, "samples": [{"hash": "gtCEkXRklNE", "uri": "/contracts/gtCEkXRklNE#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 26.695601101, "published": true}], "snippet": "Quintiles a/nebo Zadavatel jsou opr\u00e1vn\u011bni ukon\u010dit platnost t\u00e9to Smlouvy z jak\u00e9hokoli d\u016fvodu s okam\u017eitou \u00fa\u010dinnost\u00ed neprodlen\u011b na z\u00e1klad\u011b doru\u010den\u00ed p\u00edsemn\u00e9ho ozn\u00e1men\u00ed. Zdravotnick\u00e9 za\u0159\u00edzen\u00ed je opr\u00e1vn\u011bno ukon\u010dit platnost t\u00e9to Smlouvy p\u00edsemn\u00fdm ozn\u00e1men\u00edm v p\u0159\u00edpad\u011b, \u017ee okolnosti, je\u017e jsou svoj\u00ed povahou mimo mo\u017enost ovlivn\u011bn\u00ed ze strany Zdravotnick\u00e9ho za\u0159\u00edzen\u00ed, zabr\u00e1n\u00ed dokon\u010den\u00ed Studie, nebo v p\u0159\u00edpad\u011b, \u017ee Zdravotnick\u00e9 za\u0159\u00edzen\u00ed", "snippet_links": [{"key": "zdravotnick\u00e9-za\u0159\u00edzen\u00ed", "type": "clause", "offset": [165, 186]}, {"key": "dokon\u010den\u00ed-studie", "type": "clause", "offset": [363, 379]}], "hash": "a8470cbec35813c82cc27ec17eb3ad1c", "id": 7}, {"size": 2, "samples": [{"hash": "2BIQtmc410N", "uri": "/contracts/2BIQtmc410N#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 28.403718471, "published": true}, {"hash": "6H8XsrlLkpu", "uri": "/contracts/6H8XsrlLkpu#ukon\u010den\u00ed-platnosti", "label": "Clinical Trial Agreement", "score": 24.2518822724, "published": true}], "snippet": "Subject to prior written notice Sponsor may terminates this Agreement upon earlier of any of the following events: a.", "snippet_links": [{"key": "subject-to", "type": "definition", "offset": [0, 10]}, {"key": "prior-written-notice", "type": "definition", "offset": [11, 31]}, {"key": "this-agreement", "type": "clause", "offset": [55, 69]}], "hash": "97e97b6f9a05651540aaf3ef1abe39e1", "id": 8}, {"size": 2, "samples": [{"hash": "f8m0XVY05p3", "uri": "/contracts/f8m0XVY05p3#ukon\u010den\u00ed-platnosti", "label": "Observational Study Agreement", "score": 28.4858394985, "published": true}, {"hash": "BRQ2KO3pr3", "uri": "/contracts/BRQ2KO3pr3#ukon\u010den\u00ed-platnosti", "label": "Observational Study Agreement", "score": 22.5126625599, "published": true}], "snippet": "This Agreement may be terminated: Platnost t\u00e9to Smlouvy lze ukon\u010dit:", "snippet_links": [{"key": "agreement-may-be-terminated", "type": "clause", "offset": [5, 32]}], "hash": "4155d409439afe80a0ac88ed619e1647", "id": 9}, {"size": 2, "samples": [{"hash": "gmwncSjaBoj", "uri": "/contracts/gmwncSjaBoj#ukon\u010den\u00ed-platnosti", "label": "Ancillary Services Agreement", "score": 29.4748929274, "published": true}, {"hash": "7V6dXiFFSNi", "uri": "/contracts/7V6dXiFFSNi#ukon\u010den\u00ed-platnosti", "label": "Ancillary Services Agreement", "score": 27.2042385467, "published": true}], "snippet": "IQVIA may terminate this Agreement effective immediately upon written notice. Service Provider may terminate upon written notice if circumstances beyond Service Provider\u2019s reasonable control prevent Service Provider from completing the Services, or if Service Provider reasonably determines that it is unsafe to continue the Services. 9.1 Spole\u010dnost IQVIA m\u016f\u017ee tuto Smlouvu vypov\u011bd\u011bt p\u00edsemn\u011b s okam\u017eitou \u00fa\u010dinnost\u00ed. Poskytovatel slu\u017eeb je opr\u00e1vn\u011bn ukon\u010dit platnost t\u00e9to Smlouvy p\u00edsemn\u00fdm ozn\u00e1men\u00edm v p\u0159\u00edpad\u011b, \u017ee v dokon\u010den\u00ed Slu\u017eeb zabr\u00e1n\u00ed Poskytovateli slu\u017eeb okolnosti, kter\u00e9 nebude moci s vynalo\u017een\u00edm p\u0159im\u011b\u0159en\u00e9ho \u00fasil\u00ed ovlivnit, nebo v p\u0159\u00edpad\u011b, \u017ee Poskytovatel slu\u017eeb d\u016fvodn\u011b usoud\u00ed, \u017ee dal\u0161\u00ed poskytov\u00e1n\u00ed Slu\u017eeb nen\u00ed bezpe\u010dn\u00e9.", "snippet_links": [{"key": "upon-written-notice", "type": "clause", "offset": [57, 76]}, {"key": "service-provider", "type": "definition", "offset": [78, 94]}, {"key": "reasonable-control", "type": "clause", "offset": [172, 190]}, {"key": "the-services", "type": "definition", "offset": [232, 244]}], "hash": "57b940b4a2a40039774e2a832c13696b", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih11a29uxI1lbsOtLXBsYXRub3N0aSMwMDAwMDAwYQyiAQJlbhgAIAA=", "clause": {"size": 114, "parents": [["termination", "Termination"], ["debarment", "Debarment"], ["independent-contractors-14-nez\u00e1visl\u00ed-dodavatel\u00e9", "Independent contractors 14 NEZ\u00c1VISL\u00cd DODAVATEL\u00c9"], ["term-termination", "Term & Termination"], ["study-subject-injury-indemnification-insurance-and-damages", "Study Subject Injury, indemnification, INSURANCE AND DAMAGES"]], "children": [["", ""], ["entire-agreement", "Entire Agreement"], ["no-waiver-enforceability", "No Waiver/Enforceability"], ["celistvost-\u2587\u2587\u2587\u2587\u2587\u2587\u2587", "Celistvost \u2587\u2587\u2587\u2587\u2587\u2587\u2587"], ["termination-for-breach", "Termination for Breach"]], "title": "Ukon\u010den\u00ed platnosti", "id": "ukon\u010den\u00ed-platnosti", "related": [["p\u0159etrvaj\u00edc\u00ed-platnost", "P\u0159etrvaj\u00edc\u00ed platnost", "P\u0159etrvaj\u00edc\u00ed platnost"], ["p\u0159etrv\u00e1vaj\u00edc\u00ed-platnost", "P\u0159etrv\u00e1vaj\u00edc\u00ed platnost", "P\u0159etrv\u00e1vaj\u00edc\u00ed platnost"], ["du\u0161evn\u00ed-vlastnictv\u00ed", "DU\u0160EVN\u00cd VLASTNICTV\u00cd", "DU\u0160EVN\u00cd VLASTNICTV\u00cd"], ["povinnosti", "Povinnosti", "Povinnosti"], ["lokasi-\u2587\u2587\u2587-keterangan-hartanah", "LOKASI \u2587\u2587\u2587 KETERANGAN HARTANAH", "LOKASI \u2587\u2587\u2587 KETERANGAN HARTANAH"]], "related_snippets": [], "updated": "2025-07-07T12:36:22+00:00", "also_ask": [], "drafting_tip": "", "explanation": "The \"Ukon\u010den\u00ed platnosti\" clause defines the conditions and procedures under which an agreement or contract comes to an end. It typically outlines the specific events, such as expiration of a fixed term, mutual agreement, or breach of contract, that trigger the termination of the contract. This clause ensures that both parties understand when and how their obligations will cease, providing clarity and reducing the risk of disputes regarding the contract's duration or the process for ending the relationship."}, "json": true, "cursor": ""}}